Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

TIKKS

Financiado

Cerrado

Innovative insight into the endogenous kallikrein-kinin system in tissue in heal...

Innovative insight into the endogenous kallikrein-kinin system in tissue in health and disease state Cardiovascular diseases, cancer, and sepsis are the leading causes of death worldwide. In all of them, a strong involvement of the endogenous kallikrein-kinin system (KKS) is postulated. However, the KKS is only rudimentarily unde... ver más

30/04/2025

UDUS

266K€

Presupuesto del proyecto: 266K€

Líder del proyecto

HEINRICH-HEINE-UNIVERSITAET DUESSELDORF No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-05-13

HORIZON-MSCA-2021-PF-01-01: MSCA Postdoctoral Fellowships 2021 ExpectedOutcome:

I+D

Cerrada hace 3 años

0% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

UDUS

265.65K€ | Lider

BAYLOR COLLEGE OF MEDICINE

BCM

N.D. | Participante

Proyectos interesantes

ANGIOTOX

Medical Technol...

Data Science

2M€ Cerrado

CARDIOTOX

Medical Technol...

Data Science

243K€ Cerrado

CaReSyAn

Medical Technol...

Data Science

3M€ Cerrado

SENSITIVITYMARKERS

Medical Technol...

Data Science

71K€ Cerrado

IMODE-CKD

Medical Technol...

Data Science

3M€ Cerrado

SAF2014-53977-R

Medical Technol...

Data Science

Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 35 meses Fecha Inicio: 2022-05-13
Fecha Fin: 2025-04-30

Líder del proyecto

HEINRICH-HEINE-UNIVERSITAET DUESSELDORF No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 266K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cardiovascular diseases, cancer, and sepsis are the leading causes of death worldwide. In all of them, a strong involvement of the endogenous kallikrein-kinin system (KKS) is postulated. However, the KKS is only rudimentarily understood, which is also reflected by the large proportion of developed drugs showing insufficient efficacy. The KKS is a 2-arm cascade that is present in both the blood as well as the tissue and its actions are mediated by the so-called kinins. Comprehensive insight into the cascade is greatly hindered by the lack of appropriate bioanalytical techniques. While the fellow has recently developed an innovative mass spectrometric method for the plasma KKS and applied in clinical studies, the tissue KKS has not yet been investigated, although the physiological action is likely exerted only in tissue. The advances in mass spectrometric imaging are currently used for metabolomics or mapping of biomolecules in tissue, but appear to be highly promising also for targeted kinin detection in the tissue KKS. The fellow with his key expertise in targeted mass spectrometric kinin quantification will use different mass spectrometric imaging techniques (DESI, MALDI, MasSpec Pen) to evaluate the tissue KKS. Hence, the TIKKS project is to first time study the presence, distribution, metabolism and overall profile of kinins in different (diseased) tissues by mass spectrometric imaging. For this purpose, various malignant tissues are examined as a main objective and subsequently extended to cardiovascular diseases and angioedema. This innovative approach will allow the fellow to uniquely investigate physiology and pathophysiology across both arms of the KKS (tissue & plasma) and therefore strengthen him on his path to his own professorship. The combined power of the innovative imaging approach and the already established mass spectrometric platform for plasma KKS will critically accelerate the discovery of promising drug targets for non-communicable diseases.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores